Global Immunohistochemistry Market by Products (Antibodies, Equipment, Reagents and Kits) by Applications (Diagnostics and Drug Testing) - Growth, Future Prospects & Competitive Analysis, 2017 – 2025

The most common application of immunohistochemistry is to study and identify the site of origin of metastatic tumor when the primary site has already been identified. Technological advancement in the panel of immunostains can be helpful in resolving all diagnostic problems. Recent antibodies such as cadherin-17, SATB2, CDX-2 and villin have found application in the differential diagnosis of suspected metastatic adenocarcinoma. A strong limitation of immunohistochemistry is the number of parameters that can be detected, and the capacity of multiplexing immunohistochemistry is very limited.

For the purpose of this study, the various products studied includes antibodies, equipment, reagents and kits. The applications are classified as diagnostics and drug testing. Antibodies are further classified as (primary antibodies, secondary antibodies). Equipment’s are categorized as (slide staining systems, tissue microarrays, tissue processing system, slide scanners and others). Reagents are further sub segmented as (histological stains, blocking sera and reagents, chromogenic substrates, fixation reagents, stabilizers, organic solvents, proteolytic enzymes and diluents). Diagnostics are further segmented as (cancer, infectious diseases, cardiovascular diseases, autoimmune diseases, diabetic mellitus, and nephrological diseases). Market size estimates and forecast of these segments for the period 2015 to 2025 are provided in terms of US$ Mn along with the respective CAGRs for the period 2017 to 2025, considering 2016 as the base year.

The geographic segmentation of the global immunohistochemistry market is performed for the regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa markets. The regions are also further sub-segmented on the basis of major countries:

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Rest of Asia Pacific
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East and Africa
  • GCC
  • Rest of Middle East and Africa

Market size estimates and forecast for these segments for the period 2015 to 2025 are provided in terms of US$ Mn along with the respective CAGRs for the period 2017 to 2025, considering 2016 as the base year.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global immunohistochemistry market. Market attractiveness assessment and competitive landscape analysis by key players are also presented in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the global immunohistochemistry market. The key players profiled in this report are Abcam plc, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BioSB, Cell Signaling Technology, Inc., Danaher Corporation, F. Hoffman La-Roche Ltd., Merck Millipore Corporation, Perkin Elmer, Inc., and Thermo Fisher Scientific, Inc.

Based on product types, the global immunohistochemistry market is categorized into

• Antibodies
  • Primary Antibodies
  • Secondary Antibodies
• Equipment
  • Slide Staining Systems
  • Tissue Microarrays
  • Tissue Processing Systems
  • Slide Scanners
  • Others
• Reagents
  • Histological Stains
  • Blocking Sera and Reagents
  • Chromogenic Substrates
  • Fixation Reagents
  • Stabilizers
  • Organic Solvents
  • Proteolytic Enzymes
  • Diluents
• Kits

The immunohistochemistry market is driven by factors such as rising prevalence of cancer, aging population suffering with chronic diseases and urgent requirement for novel drug discovery in cases such as multiple drug resistance bacterial infection. In addition, increasing number of diagnostic centers and increasing physician awareness regarding disease etiology will propel the deep market penetration for immunohistochemistry. In 2016, antibodies segment held the largest market share chiefly due to factors such as technological advancement in the production and development of antigen specific antibodies finding immense requirement in diagnosis and stem cell population determination etc., increasing demand for personalized medication and the recent technological advancement in biologicals for the treatment of chronic diseases.

Reagents will be the fastest growing segment throughout the forecast period 2017-2025 majorly due to factors such as rising prevalence of chronic diseases, steadily increasing diagnostic centers and public private partnership to combat life threatening diseases by setting research and development centers. The major players in immunohistochemistry market are Abcam plc, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BioSB, Cell Signaling Technology, Inc., Danaher Corporation, F. Hoffman La-Roche Ltd., Merck Millipore Corporation, Perkin Elmer, Inc., Thermo Fisher Scientific, Inc. and other notable players.

Based on applications, the global immunohistochemistry market is categorized into

• Diagnostics
  • Cancer
  • Infectious Diseases
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Diabetes Mellitus
  • Nephrological Diseases
• Drug Testing

The crucial application of immunohistochemistry is the use of antibodies being employed to study the tissue distribution of an antigen. The eukaryotic cells use histone proteins to store the DNA in the form of chromatin material, in order to understand the genetic relations to the chronic diseases the antibodies can be employed to target histones. Immunohistochemistry is a comprehensive technique which is employed for morphological characterization of tumors and other tissue malignancies. In 2016, diagnostics segment dominated the market mainly due to factors such as rising prevalence of chronic diseases requiring immediate medical intervention and increasing public health awareness resulting into the rising number of diagnostic centers. Additionally the technological advancement in the diagnostics techniques that use antibodies to identify podocalyxin (PODXL) a trans-membrane protein involved in cell-cell interaction expressed in several cancers such as breast, prostate, testicular, colorectal and urothelial cancer. The drug testing segment is anticipated to register faster growth throughout the forecast period 2017-2025, majorly due to rising incidence of drug related adverse events and study the microbe metabolism due to increasing incidence of multiple drug resistance bacterial infection.

For the purpose of this study, the global immunohistochemistry market is categorized into the following regional and country specific markets:

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • GCC
  • Rest of Middle East and Africa

North America was observed to be the largest market for immunohistochemistry in the base year 2016. According to the Center for Disease Control and Prevention, in 2012, about half of the American population suffered with one or more chronic health conditions. The dominance of North America is mainly attributed to the presence of key drivers such as rising prevalence of chronic disease, matured biotechnology market, increasing commercialization of the immunohistochemistry products and developed research and healthcare institutions. The market growth in Europe is mainly attributed to the rising prevalence of chronic diseases, as per the OECD/European Commission report 2016 approximately 550,000 premature deaths were reported across European Union. This factor boosts the demand for antibodies for the identification and screening of biomarkers related to chronic diseases and technological advancement in the tissue processing systems and chromogenic substrates employed for tissue sampling.

Asia Pacific was observed as the fastest growing regional segment throughout the forecast period 2017-2025. Factors that are anticipated to propel the market growth are the increasing number of geriatric population suffering with chronic health complications, competitive market due to presence of existing major players and evolving biopharmaceutical manufacturers producing immunohistochemistry reagents and equipment in these regions, and supportive regulatory environment for immunohistochemistry products. Moreover, factors such as developing health infrastructure, expansion of research centers by pharmaceutical giants to propel deep market penetration in the untapped market of remote areas with unmet medical needs are going to fuel the rapid growth of immunohistochemistry market in Latin America, and Middle East and Africa region in the near future.